Dr. Silver, a professor of Internal Medicine at the University of Michigan Medical School, specializes in malignant and benign hematology, and is a former director of the University of Michigan Cancer Center Network. He has been a member of the faculty since 1986 and in April 2008 he was appointed Assistant Dean for Research.
Dr. Silver received his medical degree from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency at the University of California-San Francisco and was a fellow in hematology and oncology at the University of Pennsylvania.
As medical director of U-M Health System’s Adult Bone Marrow Transplantation Program from 1990 to 1997, Dr. Silver grew the program into one of the country’s largest transplant sites.
Dr. Silver has worked as principal investigator for numerous clinical research studies involving a range of topics, such as malignant hematology and the quality of oncology care. Throughout his career, Dr. Silver has focused on issues involving practice and reimbursement issues and he is recognized nationally for his involvement in clinical reimbursement and coding.
He received the American Medical Association’s (AMA) Gordon Award for his work on its Current Procedural Terminology (CPT) Editorial Board, which identifies codes for medical procedures.
Dr. Silver established Michigan’s first statewide consortium on quality breast cancer care, and in 2008 received a Statesman Award from the American Society of Clinical Oncology for his significant volunteer efforts.
He serves on the Michigan Carrier Advisory Committee to Medicare. He is a past president and current board member of the Michigan Society of Hematology/Oncology.